Louis WC Chow

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 578 citations

5-Year Analysis, Breast Oncology, Oncology +10

Breast Cancer in Limited-Resource Countries: An Overview of the Breast Health Global Initiative 2005 Guidelines

Benjamin O. Anderson, Roman Shyyan, Alexandru Eniu et al. · The Breast Journal · 2006 · 360 citations

Participation and Satisfaction with Surgical Treatment Decision-Making in Breast Cancer Among Chinese Women

Richard Fielding, Miranda Chan, Louis WC Chow et al. · Breast Cancer Research and Treatment · 2003 · 90 citations

Nursing, Quality Of Life, Medical Decision Making +12

Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway

Xia Li, Xing‐Xing Fan, Zebo Jiang et al. · Pharmacological Research · 2016 · 89 citations

Medicine, Pathology, Bronchial Neoplasm +7

Combination neratinib (HKI-272) and paclitaxel therapy in patients with HER2-positive metastatic breast cancer

Louis WC Chow, Binghe Xu, Sudeep Gupta et al. · British Journal of Cancer · 2013 · 83 citations · Full text